Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 6, Issue 12 (2017)

Optimization of the surgical protocol in rehabilitation of stomatological patients for prophylaxis atrophy of alveolar process

Author(s):
Prots HB
Abstract:
The problem of loss of cellular bone volume is one of the most urgent in modern dentistry, which makes it impossible not only dental implantation, but also creates great difficulties for prosthetics and normal functioning of the maxillofacial complex in general. The aim of the study was to improve the technique of tooth extraction using bone-plastic material based on β-three calcium phosphate and methods for stimulating bone regeneration. 262 patients were examined in which tooth extraction was performed according to generally accepted methods and the residual bone defect was filled with blood clot (80 patients), and the post-extraction defect was filled with bone-plasticized material based on β-three calcium phosphate (69 patients) and 67 patients with bone-plastic material on basis of β-three calcium phosphate and plasma enriched by growth factors, and 46 patients with generalized paradontitis, the removal of teeth was carried out according to the technique proposed by us using osteoplastic material on the basis of three β-calcium phosphate and bone marrow. Clinical, anthropometric, radio-visual studies have been carried out. It has been shown that substitution of the post-extraction defect by an osteoplastic material based on β-tris calcium phosphate and plasma enriched with growth factors provided sufficient height after 12-14 months at the time of the surgical stage of dental implantation. The technique of removed teeth proposed by us reduced the number of postoperative complications by 18.84%, compared to patients where the usual methods were used.
Pages: 530-534  |  955 Views  73 Downloads


The Pharma Innovation Journal
How to cite this article:
Prots HB. Optimization of the surgical protocol in rehabilitation of stomatological patients for prophylaxis atrophy of alveolar process. Pharma Innovation 2017;6(12):530-534.

Call for book chapter